Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/21516
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPavlidis, N.en
dc.date.accessioned2015-11-24T19:15:27Z-
dc.date.available2015-11-24T19:15:27Z-
dc.identifier.issn0284-186X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/21516-
dc.rightsDefault Licence-
dc.subjectHumansen
dc.subjectNeoplasms, Unknown Primary/*drug therapy/mortalityen
dc.subjectSurvival Rateen
dc.titleForty years experience of treating cancer of unknown primaryen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1080/02841860701243095-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17562435-
heal.identifier.secondaryhttp://informahealthcare.com/doi/pdfplus/10.1080/02841860701243095-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2007-
heal.abstractCancer of unknown primary site (CUP) is not a rare tumour. It accounts as the seventh to eighth most frequently diagnosed cancer in a general medical oncology service. Since CUP is not a homogeneous disease and it consists of different favourable and unfavourable sub-sets, treatment of each clinicopathological entity requires a unique approach. The spectrum of therapeutic management includes both locoregional and systemic therapy and should intend to offer optimal benefit to favourable CUP patients and palliative care to unfavourable cases. This review article provides both a historical outline of CUP treatment as well as a helpful therapeutic guide to every oncologist who treats CUP patients.en
heal.journalNameActa Oncolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Pavlidis-2007-Forty years experien.pdf129.87 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons